Dose-related	dose-related	O	O	O	O
beneficial	beneficial	O	O	O	O
and	and	O	O	O	O
adverse	adverse	O	O	O	O
effects	effects	O	O	O	O
of	of	O	O	O	O
dietary	dietary	O	O	O	O
corticosterone	corticosterone	CHEMICALS	O	OTHERS	I
on	on	O	O	O	O
organophosphorus-induced	organophosphorus-induced	O	O	O	O
delayed	delayed	O	O	O	O
neuropathy	neuropathy	O	DISEASE	OTHERS	I
in	in	O	O	O	O
chickens	chickens	O	O	O	O
.	.	O	O	O	O

Tri-ortho-tolyl	tri-ortho-tolyl	O	O	O	O
phosphate	phosphate	CHEMICALS	O	OTHERS	I
(	(	O	O	O	O
TOTP	totp	O	O	OTHERS	I
)	)	O	O	O	O
,	,	O	O	O	O
360	360	O	O	O	O
mg/kg	mg/kg	O	O	O	O
,	,	O	O	O	O
po	po	O	O	O	O
,	,	O	O	O	O
and	and	O	O	O	O
0,0'-diisopropyl	0,0'-diisopropyl	O	O	OTHERS	I
phosphorofluoridate	phosphorofluoridate	O	O	OTHERS	I
(	(	O	O	O	O
DFP	dfp	CHEMICALS	O	OTHERS	I
)	)	O	O	O	O
,	,	O	O	O	O
1	1	O	O	O	O
mg/kg	mg/kg	O	O	O	O
sc	sc	O	O	O	O
,	,	O	O	O	O
were	were	O	O	O	O
administered	administered	O	O	O	O
to	to	O	O	O	O
adult	adult	O	O	O	O
White	white	O	O	O	O
Leghorn	leghorn	O	O	O	O
chickens	chickens	O	O	O	O
24	24	O	O	O	O
hr	hr	O	O	O	O
after	after	O	O	O	O
they	they	O	O	O	O
were	were	O	O	O	O
placed	placed	O	O	O	O
on	on	O	O	O	O
diets	diets	O	O	O	O
containing	containing	O	O	O	O
0	0	O	O	O	O
to	to	O	O	O	O
300	300	O	O	O	O
ppm	ppm	O	O	O	O
corticosterone	corticosterone	CHEMICALS	O	OTHERS	I
.	.	O	O	O	O

Supplemented	supplemented	O	O	O	O
diets	diets	O	O	O	O
were	were	O	O	O	O
continued	continued	O	O	O	O
until	until	O	O	O	O
clinical	clinical	O	O	O	O
signs	signs	O	O	O	O
and	and	O	O	O	O
lesions	lesions	O	O	O	O
of	of	O	O	O	O
delayed	delayed	O	O	O	O
neuropathy	neuropathy	O	DISEASE	OTHERS	I
appeared	appeared	O	O	O	O
.	.	O	O	O	O

Although	although	O	O	O	O
low	low	O	O	O	O
concentrations	concentrations	O	O	O	O
(	(	O	O	O	O
less	less	O	O	O	O
than	than	O	O	O	O
or	or	O	O	O	O
equal	equal	O	O	O	O
to	to	O	O	O	O
50	50	O	O	O	O
ppm	ppm	O	O	O	O
)	)	O	O	O	O
of	of	O	O	O	O
corticosterone	corticosterone	CHEMICALS	O	OTHERS	I
had	had	O	O	O	O
beneficial	beneficial	O	O	O	O
effects	effects	O	O	O	O
on	on	O	O	O	O
TOTP-induced	totp-induced	O	O	O	O
neuropathy	neuropathy	O	DISEASE	OTHERS	I
,	,	O	O	O	O
greater	greater	O	O	O	O
than	than	O	O	O	O
or	or	O	O	O	O
equal	equal	O	O	O	O
to	to	O	O	O	O
200	200	O	O	O	O
ppm	ppm	O	O	O	O
exacerbated	exacerbated	O	O	O	O
clinical	clinical	O	O	O	O
signs	signs	O	O	O	O
in	in	O	O	O	O
chickens	chickens	O	O	O	O
given	given	O	O	O	O
either	either	O	O	O	O
TOTP	totp	O	O	OTHERS	I
or	or	O	O	O	O
DFP	dfp	CHEMICALS	O	OTHERS	I
.	.	O	O	O	O

Neurotoxic	neurotoxic	O	DISEASE	OTHERS	I
esterase	esterase	O	O	O	O
activities	activities	O	O	O	O
24	24	O	O	O	O
hr	hr	O	O	O	O
after	after	O	O	O	O
TOTP	totp	O	O	OTHERS	I
or	or	O	O	O	O
DFP	dfp	CHEMICALS	O	OTHERS	I
were	were	O	O	O	O
less	less	O	O	O	O
than	than	O	O	O	O
20	20	O	O	O	O
%	%	O	O	O	O
of	of	O	O	O	O
values	values	O	O	O	O
measured	measured	O	O	O	O
in	in	O	O	O	O
chickens	chickens	O	O	O	O
not	not	O	O	O	O
given	given	O	O	O	O
organophosphorous	organophosphorous	O	O	OTHERS	I
compounds	compounds	O	O	O	O
.	.	O	O	O	O

Chickens	chickens	O	O	O	O
given	given	O	O	O	O
200	200	O	O	O	O
ppm	ppm	O	O	O	O
corticosterone	corticosterone	CHEMICALS	O	OTHERS	I
without	without	O	O	O	O
TOTP	totp	O	O	OTHERS	I
or	or	O	O	O	O
DFP	dfp	CHEMICALS	O	OTHERS	I
had	had	O	O	O	O
significantly	significantly	O	O	O	O
elevated	elevated	O	O	O	O
activity	activity	O	O	O	O
of	of	O	O	O	O
plasma	plasma	O	O	O	O
cholinesterase	cholinesterase	O	O	O	O
and	and	O	O	O	O
significantly	significantly	O	O	O	O
inhibited	inhibited	O	O	O	O
activity	activity	O	O	O	O
of	of	O	O	O	O
liver	liver	O	O	O	O
carboxylesterase	carboxylesterase	O	O	O	O
.	.	O	O	O	O

Degenerating	degenerating	O	O	OTHERS	I
myelinated	myelinated	O	O	OTHERS	I
fibers	fibers	O	O	OTHERS	I
were	were	O	O	O	O
also	also	O	O	O	O
evident	evident	O	O	O	O
in	in	O	O	O	O
distal	distal	O	O	O	O
levels	levels	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
peripheral	peripheral	O	O	O	O
nerves	nerves	O	O	O	O
of	of	O	O	O	O
chickens	chickens	O	O	O	O
given	given	O	O	O	O
TOTP	totp	O	O	OTHERS	I
or	or	O	O	O	O
DFP	dfp	CHEMICALS	O	OTHERS	I
.	.	O	O	O	O

